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During influenza virus infection, transcription and replication of the viral RNA take place in the cell nucleus. Directly after entry in the
nucleus the viral ribonucleoproteins (RNPs, the viral subunits containing vRNA, nucleoprotein and the viral polymerase) are tightly
associated with the nuclear matrix. Here, we have analysed the binding of RNPs, M1 and NS2/NEP proteins to purified nucleosomes,
reconstituted histone octamers and purified single histones. RNPs and M1 both bind to the chromatin components but at two different sites,
RNP to the histone tails and M1 to the globular domain of the histone octamer. NS2/NEP did not bind to nucleosomes at all. The possible
consequences of these findings for nuclear release of newly made RNPs and for other processes during the infection cycle are discussed.
D 2004 Published by Elsevier Inc.
Keywords: Influenza A virus; M1 protein; Nucleoprotein; Replication; Nuclear matrix; HistonesIntroduction
Influenza virus is a segmented negative strand RNAvirus.
The eight RNA segments of its genome encode a total of 10
genes. The eight viral RNAs are associated with the
polymerase subunits (PA, PB1 and PB2) and the nucleopro-
tein (NP) into structurally distinct ribonucleoprotein particles
(RNPs) (Duesberg, 1969; Compans et al., 1972; Heggeness
et al., 1982; Murti et al., 1988). Matrix protein (M1) is
located between the RNP and the inner surface of the lipid
envelop in the intact virion (Ruigrok et al., 1989; Schulze,
1972) and acts as a multifunctional protein, playing a role in
several steps of the replication of influenza virus. Two major
external glycoproteins, haemagglutinin (HA) and neurami-
nidase (NA), and a small protein M2 serving as a trans-
membrane channel, are anchored in the viral envelope (Lamb
and Choppin, 1983; Sugrue and Hay, 1991).0042-6822/$ - see front matter D 2004 Published by Elsevier Inc.
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the start of the infection process, vRNPs dissociate from M1
and are released into the cytoplasm (Bui et al., 1996;
Helenius, 1992; Martin and Helenius, 1991). They are then
actively imported into the nucleus were viral transcription
and replication take place (Bui et al., 2000; Whittaker et al.,
1996). The RNPs are the structures responsible for tran-
scription and replication of viral RNA in the nuclei of
infected cells in a highly regulated process. The polymerase
complex plus NP are the minimal set of proteins required for
these activities (de la Luna et al., 1993; Huang et al., 1990;
Kimura et al., 1992; Mena et al., 1994). The polymerase
catalyses not only RNA polymerisation but also the cleavage
of host cell mRNA to generate 5V capped RNA primers of 10
to 13 nucleotides, a process known as cap-snatching (Bouloy
et al., 1978; Plotch et al., 1981; Rao et al., 2003).
In the influenza virus-infected cell, vRNPs are tightly
associated with the nuclear matrix and high salt extraction is
needed to release these vRNPs from cellular chromatin (Bui
et al., 2000). This is in agreement with the results of
Bukrinskaya et al. (1979) who found that input vRNPs were
associated with chromatin 1 h after infection and with Lo´pez-05) 329–336
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influenza virus vRNAs takes place in insoluble complexes
present in the nuclear matrix fraction. Cap snatching takes
place in the nucleus and the cap structure is removed from
newly synthesised cellular mRNAs. Therefore, one could
imagine that one of the reasons why vRNPs are tightly
associated with the nuclear matrix is that they would be close
to the transcription machinery of the host cell. It is possible
that caps have to be snatched before the cellular cap binding
protein (CBP) can interact with cellular pre-mRNAs for
further processing and nuclear export.
At the end of the infection cycle, newly synthesised
RNPs must be exported from the nucleus and directed to the
plasma membrane to allow their incorporation into budding
virions. A part of the newly synthesised M1 migrates to the
nucleus of the infected cell where it will come into close
proximity with newly synthesised RNP (Bui et al., 1996;
Patterson et al., 1988). The binding of M1 to RNP leads to
the transport of M1/RNP complexes from the nucleus to the
cytoplasm (Huang et al., 2001; Martin and Helenius, 1991)
and prevents RNP from re-entering the nucleus (Martin and
Helenius, 1991). In fact, nuclear export protein (NEP,
previously NS2) is thought to bind to M1 that is already
bound to RNP and to mediate the contact between the M1/
RNP complex and the cellular exportin, CRM1 (Akarsu et
al., 2003; Neumann et al., 2000). It has previously been
reported that M1 binds to the histones of the nucleosome
(Zhirnov and Klenk, 1997) indicating that there is a specific
interaction of M1 with the nucleosomes during viral
replication and M1 could be involved in the release of
vRNPs from the chromatin.
In this work, we present in vitro experiments studying the
interactions between nucleosome particles and vRNPs and
purified NP. Positive results were found with all core his-
tones, the histone octamer particle and purified mononu-
cleosomes but not with the linking histone H1. These results
suggest that the observed association of vRNPs with the
nuclear matrix in vivo is most probably achieved through
the NP protein and that the binding takes place through the
histone tails as the interaction disappears when the tails are
removed by trypsin digestion. The interaction with the nu-
cleosomes of the other two proteins involved in nuclear
export of vRNPs, M1 and NEP was also studied. We found
that M1 does interacts with the nucleosome but not at the
same site as NP. NEP did not show any interaction with
nucleosomes.
Fig. 1. Binding of vRNPs or purified nucleoprotein free of RNA (NP) to
nucleosomes (panel A) and to reconstituted histone octamers (panel B).
RNPs or NP were mixed with nucleosomes or with reconstituted octamers.
After 1 h incubation the mixture was sedimented through a 40% glycerol
cushion (for nucleosomes) or through a 20% glycerol cushion (for
octamers). The pellets were resuspended and analysed on 15% SDS-PAGE.
(A) Supernatant (sn) or pellet fractions of the various mixtures as indicated
above the gel, the type of virus from which the RNP or nucleocapsid (NC)
was derived below the gel. MW: molecular weight markers. The gels were
stained with Coomassie blue. (B) As in panel A but only performed with
influenza virus RNP or NP and using histone octamers (Oct) rather than
intact nucleosomes.Results
vRNPs and NP bind to nucleosomes, histone octamers and
single histones
Influenza vRNPs and purified NP were used to test their
ability to bind to chromatin components. We performed
pelleting experiments with purified mononucleosomes fromHeLa cells. Mononucleosomes were incubated for 1 h either
with vRNPs or with NP purified from influenza virus. NP
forms polymeric structures that are indistinguishable from
intact vRNPs (Ruigrok and Baudin, 1995) and, therefore,
sedimentation experiments can be performed under the same
conditions. The mixture was loaded onto a 40% glycerol
cushion. Mononucleosomes alone do not pellet under the
conditions used. Presence of mononucleosomes in the pellet
together with vRNP or purified NP indicates the formation
of a complex. Indeed, nucleosomes alone pellet only to a
very low amount, but RNPs and NP take a large amount of
nucleosomes with them to the pellet (Fig. 1A). In order to
confirm the specificity of this interaction, similar experi-
ments were performed with recombinant nucleocapsids
(NC) from measles and rabies virus, two viruses that
replicate in the cytoplasm of the infected cell and that are
not expected to form functional complexes with nucleo-
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nucleocapsids and purified mononucleosomes (Fig. 1A).
The fact that nucleosomes bind to vRNPs to the same extent
as to NP suggests that the interaction between nucleosomes
and vRNPs occurs through an amino acid sequence present
on NP which is exposed on vRNPs.
We then tested the different components of the nucleo-
some in order to determine if this interaction was due to
NP–DNA or to NP–histone interaction. For this purpose,
purified histones were used to reconstitute an octamer
particle. Sedimentation assays were performed with recon-
stituted octamer mixed with vRNP or purified NP. After 1 h
incubation and sedimentation through a 20% glycerol
cushion, we observed that the octamer pelleted with either
vRNPs or NP (Fig. 1B). Controls performed with octamer
alone showed no sedimentation through 20% glycerol.
These results show that vRNPs and NP protein interact
with the nucleosome core in the absence of DNA thus
indicating a protein–protein interaction.
Purified core histones were also tested individually in
pelleting experiments with vRNPs or NP. All four core
histones were found in the pellet with vRNPs and NP (Figs.
2A and B). Controls were performed with histones alone
that did not sediment (Fig. 2, lane C in all gels). All core
histones seem to bind equally well to RNP and NP, but
when similar experiments were repeated with the linker
histone H1, no interaction was detected (Fig. 2A). Thus,
vRNPs and NP bind to core histones of the nucleosome but
not to the linker histone.Fig. 2. Binding of isolated histones to vRNPs and NP. Isolated histones: H2A, H2B
h, and mixtures were sedimented through a 20% glycerol cushion. The pellets
histones without RNP or NP. Histone conditions 1 and 2: increasing amounts of his
methods. H3m and H3d: monomers and dimers of H3 respectively.vRNPs interact with histone tails
In order to determine which domain of the nucleosome
was involved in binding to vRNP, nucleosomes were treated
with trypsin in order to remove the histone tails. The same
experiments as described above were performed with
vRNPs. When the histone tails are removed, the nucleo-
somes no longer pelleted with the vRNPs (Fig. 3).
M1 binds to nucleosomes
As M1 protein is known to enter the nucleus at the end
of the infection process, we also tested its ability to bind to
the chromatin components. Nuclear M1 translocation is
achieved via its NLS motif located between residues 101
and 105 (Ye et al., 1995). Sedimentation assays were
performed with bacterially expressed M1 and purified
nucleosomes. After 1-h incubation, the samples were
loaded onto a 20% glycerol cushion. At this concentration,
nucleosomes are able to pellet but not M1. Pellets were
analysed on 15% SDS-PAGE gels. We observed that
nucleosomes and M1 pelleted through the glycerol cushion
(Fig. 4A) confirming the results of Zhirnov and Klenk
(1997). In order to test which domain of M1 was involved
in this interaction, similar tests were performed with
nucleosomes and the N-terminal (aa 1–164) or the C-
terminal domain of M1 (aa 165–252), described in Baudin
et al. (2001). No interaction was observed for either domain
(Fig. 4B). We also tested an M1 mutant in which the amino, H3, H4 or H1 were mixed with vRNPs (A) or with NP (B), incubated for 1
were resuspended and analysed on 15% SDS-PAGE. C: control, pellet of
tones with constant amount of vRNPs (or NP) as indicated in Materials and
Fig. 4. Binding of M1 protein or NEP (A) and M1 mutants or M1 domains
(A and B) to intact nucleosomes and to tail-less nucleosomes (C). Viral
proteins were incubated with nucleosomes or trypsin-treated nucleosomes
for 1 h and the mixtures were then sedimented through a 20% glycerol
cushion.
Fig. 3. Binding of vRNPs to tail-less nucleosomes (NucT). After 1 h
incubation vRNP F nucT complexes were sedimented through a 40%
glycerol cushion and pellets were resuspended and checked on 15% SDS-
PAGE gels. Controls were performed with intact nucleosomes.
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alanines (Akarsu et al., 2003; Elster et al., 1997). These
amino acids are located on the positively charged face of
the N-terminal domain of M1 (Arzt et al., 2001; Sha and
Luo, 1997). The interaction of the MNLS mutant with
nucleosomes was strongly reduced (Fig. 4A). This reduc-
tion of binding to the nucleosome cannot be ascribed to
misfolding of the mutant protein, as its N-terminal domain
has essentially the same structure as that of wild type M1
(Arzt et al., 2004). These results would indicate that full-
length M1 protein is needed for the interaction with
nucleosomes and that the positive face of M1 is important
for this interaction.
M1 still binds to nucleosomes when the histone tails are
removed
In order to determine which domain of the nucleosome is
involved in the binding of M1, trypsin-treated nucleosomes
were used to perform sedimentation assays with M1 protein.
M1 pellets both with intact nucleosomes and with trypsin-
treated nucleosomes (Fig. 4C). Controls were performed
with M1 alone and no sedimentation was observed. This
result suggests an interaction between M1 and the nucleo-
some core independent of the histone tails thus indicating
that the vRNPs and M1 have two different binding sites on
the nucleosome.
NEP does not bind to nucleosomes
NEP protein also enters the cell nucleus at the end of the
viral cycle and is involved in the export of vRNPs from the
nucleus to the cytoplasm (Akarsu et al., 2003; Neumann et
al., 2000). Centrifugation experiments were performed with
NEP and nucleosomes. After 1-h incubation, samples were
loaded on a 20% glycerol cushion. The absence of NEP inthe pellet suggests that NEP does not interact with
nucleosomes (Fig. 4A).
Can M1 displace vRNPs from nucleosomes?
A fixed amount of each histone (Fig. 5A, condition 2
from Fig. 2) or purified nucleosomes (Fig. 5B) was
incubated in the presence of vRNPs for 30 min and
increasing amounts of purified M1 protein were then added
and incubated for a further 15 min. The mixture was then
sedimented by centrifugation through a 40% glycerol
cushion. At this glycerol concentration, only vRNPs are
Fig. 5. Mixing vRNP plus M1 with histones or nucleosomes. (A) vRNPs plus a fixed amount of each single histone (H2A, H2B, H3 or H4) were incubated for
30 min. M1 was then added to the mixture and incubated for further 15 min as described in Materials and methods. (B) vRNPs were incubated with a fixed
amount of nucleosomes for 30 min and then M1 was added and incubated for 15 min as described in Materials and methods. Single histones-vRNP F M1
complexes were sedimented through a 20% glycerol cushion whereas nucleosome-vRNP F M1 complexes were sedimented through a 40% glycerol cushion.
All lanes are pellet fraction.
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or nucleosomes in the pellet. The presence of M1 had no
influence on the NP/histone stoichiometry. So, under these
in vitro conditions, M1 does not displace RNPs from
nucleosomes. This experiment was also performed by
adding all viral components at the same time to the
nucleosomes or first M1 and then vRNPs but the results
were always the same as those shown in Fig. 5.Discussion
Here, we present simple in vitro experiments that
measure the binding of RNP, purified NP, M1 and NEP to
nucleosomes, histone octamers or isolated histones. RNP
and NP bind to the positively charged histone tails of the
nucleosome. Nucleoprotein is also a protein with a strong
net positive charge but this charge is probably neutralised by
the bound viral RNA. The fact that both RNP and NP bind
suggests that the RNA is not involved in binding and neither
is it likely that the polymerase is involved but rather somepart of NP that is not involved in binding the viral RNA and
that is exposed on the surface of the RNPs. M1 binds with
the positively charged side of its amino-terminal domain to
the globular domains of the histone octamer and the
nucleosomes. Neither the isolated amino- nor the carboxy-
terminal domain bind to the nucleosomes, in agreement with
the results of Zhirnov and Klenk (1997). This may be
because the isolated N-terminal domain has another
conformation than that in the intact protein or that the C-
terminal domain interferes with the exposition of the
positive patch on the N-terminal domain. Another possi-
bility is that the intact protein has a tendency to oligomerise
(Baudin et al., 2001) and that the multiple affinity of the
oligomer is stronger than the affinity of the monomeric N-
terminal domain. A similar situation was observed for the
transcription inhibition activity of M1 where the C-terminal
domain of M1 does bind to viral RNPs but only the intact
M1 can inhibit the transcription by these RNPs in vitro
(Baudin et al., 2001).
At a late stage in the infection, vRNPs have to be
separated from chromatin and exported towards the cytosol
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evidence that export requires the synthesis of M1 (Martin
and Helenius, 1991). M1 probably guides the vRNPs from
the nuclear matrix and through the nuclear pores together
with NEP serving as a bridge for the binding of CRM1
(Akarsu et al., 2003; Neumann et al., 2000; O’Neill et al.,
1998). Alternatively, it may be needed to release the bound
vRNPs from the nuclear matrix as suggested by Zhirnov and
Klenk (1997). The results presented here do not really
explain how M1 may perform the latter function. In the
RNP–M1–NEP complex, NEP binds to the positively
charged side of the N-terminal domain of M1 and the C-
terminal domain of M1 binds to the RNP (Akarsu et al.,
2003) so it is unlikely that the M1 that is bound to the
nucleosomes will bind NEP at the same time. NEP by itself
is unlikely to have an influence on the binding of RNPs to
chromatin since it does not directly bind to RNP (Akarsu et
al., 2003) and it does not bind to nucleosomes either (this
work). When we wanted to study the possible competition
between histones and NEP for the same site on M1, we
obtained a surprising result: all three components were
found in the pellet (result not shown). The most likely
explanation for this finding is that M1 polymerised onto M1
that was already bound to the nucleosomes and that NEP
could bind to this bsecondarilyQ polymerised M1. Therefore,
this experiment did not tell us much about what may happen
in the infected cell nucleus. In fact, there is not much known
about what actually happens in the nucleus during the
infection by influenza virus in terms of chromatin remo-
delling or reorganisation of the nucleus. It is possible that
cellular factors are involved that alter the chromatin and that
contribute to the release of the RNP. Modification (acety-
lation) of the histone tails could influence the binding of the
RNPs.
Finally, binding of RNP to the histone tails could
have another beneficial effect for the virus. Post-transla-
tional modification of the histone tails modulates the
structure and function of chromatin (Bertin et al., 2004;
Hampsey and Reinberg, 2003; Morales and Richard-Foy,
2000). By sequestering the histone tails, the interaction
between influenza virus RNP and chromatin could
disturb the chromatin structure and change the tran-
scription pattern in the infected cell, which may be
beneficial for the virus.Materials and methods
Viral proteins
M1, M11–164, M1165–252 and NEP were produced in
Escherichia coli as described (Akarsu et al., 2003; Baudin et
al., 2001). M1NLS mutant protein, with all positively
charged amino acids between residues 95 and 105 changed
to alanines (95-AA-VALYAALAA-105, changed residues
underlined) was described in Elster et al. (1997). Theisolation and purification of viral RNPs and NP from
influenza virus was described in Baudin et al. (1994).
Recombinant NC from measles virus was purified as
described in Schoehn et al. (2004) and recombinant NC
from rabies virus was purified as described in Iseni et al.
(1998).
Histones and histone octamers
Xenopus laevis core histone clones were obtained from
P. Becker (Munich). H1 histone was purchased from
Roche Biochemicals. The expression, purification, refold-
ing of histones H2A, H2B, H3 and H4 and posterior
octamer reconstitution was performed as described in
Clapier et al. (2001). Briefly, the four histones were
dissolved in unfolding buffer (7 M Guanidinium HCl, 20
mM Tris–HCl pH 7.5, 10 mM DTT) for 2 h. For
octamer reconstitution, 2 mg of each histone were mixed
at RT for 30 min, and then dialysed against refolding
buffer (2 M NaCl, 10 mM Tris–HCl pH 7.5, 1 mM Na-
EDTA pH 8 and 5 mM h-mercaptoethanol). The octamer
species were separated from tetramers and dimers by
running a FPLC S200 Column (Pharmacia) in the same
buffer. The octamer was stored in 10% glycerol at
20 8C.
Nucleosome preparation
HeLa Nuclei were purchased from 4C Biotech SA
(Belgium). Mononucleosomes were prepared by adapting
the protocol of Ausio and van Holde (1986). Briefly,
nuclei were washed twice with 0.5 mM sodium metabi-
sulfite, 5 mM MgCl2, 1 mM CaCl2, 0.5 mM Benzamidine
HCl, 50 mM NaCl, 0.5 mM DTT, 10 mM PIPES pH 6.8
and 0.1 mM PMSF. After incubation for 10 min at 37 8C
250 units/ml of Mnase (Worthington) were added and the
nuclei were further incubated for 30 min at 37 8C. The
reaction was stopped by addition of 0.5 M EDTA (4 mM
final). The appropriate Mnase amount to obtain mono-
nucleosomes was established previously by testing from
0.05 units to 25 units in a small-scale experiment. Samples
were precipitated and DNA size was monitored on agarose
gels stained with ethidium bromide. Mnase treated nuclei
were spinned at 2000  g for 5 min at 4 8C. The pellet
was resuspended in the same volume of EDTA/NaCl
solution (0.4 mM EDTA, 0.5 M NaCl) at 4 8C to lyse the
nuclei and centrifuged at 12,000  g for 10 min at 4 8C.
The supernatant, containing mononucleosomes, H1 and
H5, was loaded on a 5–30% sucrose gradient and
centrifuged in an SW 28 rotor at 26,000 rpm 4 8C for
16 h. Gradients were fractionated from the bottom and
fractions checked in 15% SDS-PAGE gels. Fractions
containing nucleosomes but not H1 or H5 were used for
further experiments. Purity and integrity of the mono-
nucleosomes were checked by 15% SDS-PAGE gels and
electron microscopy.
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Mononucleosome particles (50 Ag of protein) were
digested with trypsin at an enzyme substrate ratio of
1:1000 for 15 min at 37 8C (protocol adapted from Ausio
et al., 1989). The appropriate length of digestion (usually
15–20 min) was established through a time-course experi-
ment, which was monitored with a 15% SDS-PAGE
polyacrylamide gel. The reaction was stopped by addition
of Pefablock (Roche) (40 mM final) to the reaction tube.
Samples were used immediately in sedimentation assays.
Histones F vRNP (or NP) pelleting experiments
Five picomoles of RNP was incubated for 1 h at room
temperature with increasing amounts of single histone H2A,
H2B, H3 or H4. H2A—condition 1: 15 Ag corresponding to
1000 pmol; condition 2: 30 Ag; H2B—condition 1: 8 Ag
corresponding to 600 pmol; condition 2: 12 Ag; H3—
condition 1: 12 Ag corresponding to 800 pmol; condition 2:
20 Ag; and H4—condition 1: 8 Ag corresponding to 700
pmol; condition 2: 12 Ag. The final volume was 130 Al in 50
mM Tris–HCl pH 7.5, 150 mM NaCl and 5 mM MgCl2.
The histone F vRNP mixture was put on top of a 20%
glycerol cushion (420 Al in the same buffer as above) and
centrifuged for 1 h at 50 krpm in a SW55 rotor at 12 8C. The
controls were done with the histone proteins alone at the
higher concentration. The pellets were solubilised in SDS-
PAGE sample buffer and directly analysed on SDS-PAGE.
Similar experiments were performed with purified NP free
of RNA and with H1 protein except that only one condition
was tested for this histone, 50 Ag corresponding to 1600
pmol. A control was done with H1 alone.
OctamerF vRNP (or NP) and nucleosome F vRNP (or NP)
pelleting
Five picomoles of RNP were incubated for 1 h at room
temperature with 230 pmol of reconstituted octamer and
loaded on a 20% glycerol cushion. Sedimentation using
nucleosomes was performed as above except that 35 Ag
(220 pmol) of material was used in NP and vRNPs
experiments and that the glycerol cushion was 40%.
Recombinant NC from measles and rabies virus were
used to check the specificity of the binding to nucleosome
by performing similar experiments with 20 Ag of each and
35 Ag of nucleosome. After 1 h incubation, samples were
loaded on 40% glycerol cushion and pellets checked on
15% SDS-PAGE gels.
Nucleosomes F M1 or NEP pelleting experiments
Before using M1 and NEP in co-sedimentation experi-
ments, all protein preparations were centrifuged at 20 psi in
a Beckman airfuge to remove pre-existing aggregates.
Thirty-five micrograms of nucleosomes were used toperform pelleting experiments as described above with M1
protein (25 to 100 Ag), M11–164 (50 Ag), M1165–252 (30 Ag),
NEP (50 Ag) or M1NLS (100 Ag). After 1-h incubation, the
samples were loaded on a 20% glycerol cushion. Controls
were done with the proteins in the absence of nucleosomes.
Pellets were resuspended in SDS-PAGE loading buffer and
run on 15% PAGE gels.
Pelleting experiments with tail-less nucleosomes F M1 or
F vRNPs
Tail-less nucleosomes (NucT) were immediately used for
co-sedimentation experiments with M1 protein (100 Ag) or
vRNPs (20 Ag). Controls were done with M1 alone and
trypsin treated nucleosomes alone. After 1 h incubation,
samples were loaded on a 20% glycerol cushion for the
nucleosome T F M1 experiment or a 40% glycerol cushion
for tail-less nucleosomes F vRNP experiment. After ultra-
centrifugation for 1 h at 50 krpm in a SW55 Beckman rotor,
the pellets were resuspended in SDS-PAGE sample buffer
and loaded on 15% PAGE gels.
Pelleting of histone–vRNP–M1 mixtures
For the experiment shown in Fig. 5, histones and vRNP
were incubated for 30 min and then intact M1 protein (1 or 2
nmol) was added. The incubation proceeded for another 15
min and the histone–vRNP–M1 mixture was loaded on top
of a 20% glycerol cushion (420 Al in the buffer S) and
centrifuged for 1 h at 50 krpm in a SW55 rotor at 12 8C.
Controls were performed with proteins in the absence of
vRNP. The pellets were solubilised in SDS-PAGE sample
buffer and directly analysed on PAGE. Similar experiments
were performed with vRNPs, purified nucleosomes and M1
protein, except that only the highest amount of M1 from the
previous experiment was used. After incubation, the
samples were loaded on a 40% glycerol cushion. All
variations of mixing the three components were tried but
with the same result as that shown in Fig. 5.Acknowledgments
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